Document is current

Article History

Accepted: 11 June 2024

First Online: 13 July 2024

Declarations

:

: This study was funded by Janssen Scientific Affairs, LLC, a Johnson & Johnson company.

: M.Z., P.B., S.S., D.P., M.L., and P.L. are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Janssen Scientific Affairs, LLC, a Johnson & Johnson company, which funded the development and conduct of this study and manuscript. J.P., Q.C., and Z.C. are employees and stockholders of Janssen Scientific Affairs, LLC, a Johnson & Johnson company. NS has no disclosures.

: M.Z., P.B., S.S., D.P., M.L., and P.L. contributed to study conception and design, collection and assembly of data, and data analysis and interpretation. J.P., Q.C., Z.C., and N.S. contributed to study conception and design and data analysis and interpretation. All authors reviewed and approved the final content of this manuscript.

: The data that support the findings of this study are available from IQVIA. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the authors with the permission of IQVIA.

: Data are de-identified and comply with the patient requirements of the Health Insurance Portability and Accountability Act (HIPAA) of 1996. Per HIPAA, there are no restrictions on the use or disclosure of de-identified health information (Title 45 of CFR, Part 164.502(d)(2), 164.514(a) and (b)). eNo review by an institutional review board was required per Title 45 of CFR, Part 46.104(d)(4) because the data were de-identified.

: Not applicable.

: Not applicable.

: All analyses were conducted using SAS Enterprise Guide 7.1 (SAS Institute, Cary, NC). The SAS programs are proprietary materials of Analysis Group, Inc.; therefore, restrictions apply to the access of these codes, which cannot be made available publicly.

: Part of the material in this manuscript was presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 held 16–19 October 2023, in Orlando, FL, as poster presentation.